Fort Worth-based global alternative investment manager Crestline Investors announced the promotions of Will Palmer and Jesús Payán to partners of the firm.
“We’re pleased to name Will and Jesús as Partners,” Crestline Founding Partner Doug Bratton said in a statement. “Their hard work and dedication have played a critical role in helping Crestline tackle an ever-changing investment landscape. We look forward to their continued contributions to the firm.”
Palmer joined the firm in 2015 as a member of its Opportunistic Strategies Group, Crestline said. He currently leads the firm’s efforts in technology, media, and telecommunications for its opportunistic and direct lending strategies. Palmer is a member of the opportunistic and direct lending investment committees, and now will now join Crestline’s management committee. Before Crestline, he was vice president for the Special Situations Group at Goldman Sachs and began his career as a financial analyst with Houlihan Lokey Howard & Zukin.
Payán joined Crestline in 2006 and heads its legal and compliance team. He serves as the touchpoint for investor and counterparty relationships. He’s a member of the firm’s management committee, sits on its reinsurance company board of directors, and is integrally involved in the structuring, legal diligence, and closing of investment opportunities.
Before Crestline, Payán worked at Akin Gump Strauss Hauer & Feld LLP as an investment fund/corporate attorney.
Crestline Investors was founded in 1997 and is an institutional alternative investment management firm with roughly $18 billion in assets under management. It specializes in credit and opportunistic investments, including providing flexible capital solutions to middle market companies, asset backed investing, and financing and restructuring solutions for mature private equity funds. The firm also manages a multi-PM equity market-neutral hedge fund and provides beta and hedging solutions for institutional clients. Besides its Fort Worth headquarters, the company maintains affiliate offices in New York, London, Toronto, and Tokyo.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
Tarleton State University received the go-ahead for a new biotechnology institute as part of Texas A&M-Fort Worth's burgeoning downtown research campus. Approved in mid-August by the Texas A&M University System Board of Regents, the biotech institute is situated in one of the nation's fastest-growing life sciences hubs. "More than 5,000 biotechnology manufacturing and research and development firms — think Novartis, Alcon, AstraZeneca — call Texas home," according to the university. And DFW now ranks seventh in the U.S. for life science and biotech jobs. The Tarleton State Biotechnology Institute will focus on discovery and innovation in bioinformatics and computational modeling.…
-
North Texas has plenty to see, hear, and watch. Here are our editors' picks. Plus, you'll find more selections to "save the date."
-
You'll find deadlines coming up for a new accelerator program; and many more opportunities.
-
Situated in a reimagined space shared with Roots Coffeehouse in Near Southside, Create FW is Fort Worth's latest hub for startups and creatives. The City of Fort Worth and The DEC Network are showcasing the new entrepreneurial center on November 8. Take an advance look here.
-
Produced by Live Nation in partnership with Chef Tim Love and Larry Joe Taylor, the festival & conference's inaugural event earlier this year drew more than 3,500 attendees from more than 25 U.S. states to shows and panel discussions at 10 participating music venues in the Fort Worth Stockyards. The 2024 event will be held February 28 through March 2.
